Top Stories
L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM
Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM
Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM
Dr Reddy's Lab gets nine observations after USFDA inspection of Hyderabad unit; Stock down 1%
Oct 13, 2023
Dr Reddy's Laboratories has informed to the exchanges that the United States Food & Drug Administration (USFDA) on Thursday completed a product specific Pre-Approval Inspection (PAI) at company's biologics manufacturing facility in Bachupally, Hyderabad.
As per the regulatory filing, the inspection was conducted from October 4, 2023 to October 12, 2023, the company informed.
Dr Reddy's said, “We have been issued a Form 483 with nine observations, which we will address within the stipulated timeline.”
On Friday mid-afternoon trade, shares of Dr Reddy's Lab were trading lower by 1.01% at Rs 5474.15 per share on the BSE.
Related News
L&T Partners with PS Technology to Revolutionise Railways
6 mins read. August 2, 2024 at 12:45 PM
Jindal Saw Q1 FY24 PAT Rises 67% to Rs 441 Cr
4 mins read. August 2, 2024 at 12:41 PM
Pfizer Q1 FY25 PAT Zooms 61% to Rs 151 Cr
4 mins read. August 2, 2024 at 12:36 PM
NBCC Arm Gets Two Construction Projects Worth Rs 443.61 Cr
4 mins read. August 2, 2024 at 12:33 PM
Download app
Access BlinkX
everywhere
across device
